Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

被引：0
|
作者：
Thomas B Brunner
Rolf Sauer
Rainer Fietkau
机构：
[1] Universitätsstraße 22,Radiation Oncology of the Friedrich
[2] University of Oxford,Alexander University of Erlangen
来源：
Radiation Oncology | / 6卷
关键词：
Pancreatic cancer; chemoradiotherapy; gemcitabine; 5-fluorouracil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy of gemcitabine for locally advanced pancreatic cancer: Comparison with 5-fluorouracil-based chemoradiotherapy
    Tada, Minoru
    Arizumi, Masatoshi
    Nakai, Yousuke
    Sasaki, Takashi
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Tsujino, Takeshi
    Hirano, Kenji
    Sasahira, Naoki
    Isayama, Hiroyuki
    Kawabe, Takao
    Omata, Masao
    CHEMOTHERAPY, 2008, 54 (04) : 302 - 308
  • [32] Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5 FU) and cisplatin for locally advanced resectable esophageal cancer: A retrospective study
    Almhanna, Khaldoun
    Hoffe, Sarah
    Shridhar, Ravi
    Strosberg, Jonathan R.
    Dinwoodie, William R.
    Meredith, Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [33] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
    Tamaki, Yukihisa
    Hieda, Yoko
    Nakajima, Masanobu
    Kitajima, Kazuhiro
    Yoshida, Rika
    Yoshizako, Takeshi
    Ue, Atsushi
    Tokudo, Mutsumi
    Hirahara, Noriyuki
    Moriyama, Ichiro
    Kato, Hiroyuki
    Inomata, Taisuke
    JOURNAL OF CANCER, 2018, 9 (16): : 2765 - 2772
  • [34] Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer A meta-analysis
    Zhu, Jinfeng
    Zeng, Wei
    Ge, Lei
    Yang, Xinhui
    Wang, Qisan
    Wang, Haijiang
    MEDICINE, 2019, 98 (17)
  • [35] A PHASE-III RANDOMIZED STUDY OF 5-FLUOROURACIL AND CISPLATIN VERSUS 5-FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN-C VERSUS 5-FLUOROURACIL ALONE IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    KIM, NK
    PARK, YS
    HEO, DS
    SUH, C
    KIM, SY
    PARK, KC
    KANG, YK
    SHIN, DB
    KIM, HT
    KIM, HJ
    KANG, WK
    SUH, CI
    BANG, YJ
    CANCER, 1993, 71 (12) : 3813 - 3818
  • [36] A randomised phase II study of gemcitabine versus mitomycin C versus gemcitabine/mitomycin C in patients with advanced pancreatic cancer
    Tuinmann, G.
    Mueller, L.
    Hossfeld, D.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] A phase II study of combination chemotherapy with gemcitabine, 5-fluorouracil, and cisplatin for advanced pancreatic cancer
    Kim, S.
    Yuh, Y.
    Lee, H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 388 - 388
  • [38] Triplet therapy with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with metastatic pancreatic cancer
    Viúdez, A
    Rodríguez, J
    De la Cámara, J
    Salgado, E
    Chopitea, A
    Gil-Bazo, I
    García-Foncillas, J
    Valero, J
    Espinós, J
    Martin-Algarra, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 376S - 376S
  • [39] Clinical benefit response of concurrent chemoradiotherapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer
    Okusaka T.
    Okada S.
    Ishii H.
    Nakasuka H.
    Nagahama H.
    Yoshimori M.
    Sumi M.
    Tokuuye K.
    Kagami Y.
    Ikeda H.
    International Journal of Clinical Oncology, 1998, 3 (2) : 93 - 97
  • [40] Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
    Noriyuki Nishiwaki
    Kazuhiro Noma
    Tomoyoshi Kunitomo
    Masashi Hashimoto
    Naoaki Maeda
    Shunsuke Tanabe
    Kazufumi Sakurama
    Yasuhiro Shirakawa
    Toshiyoshi Fujiwara
    Esophagus, 2022, 19 : 626 - 638
12345